0000919574-23-004847.txt : 20230814 0000919574-23-004847.hdr.sgml : 20230814 20230814205153 ACCESSION NUMBER: 0000919574-23-004847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kynam Capital Management, LP CENTRAL INDEX KEY: 0001907884 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40791 FILM NUMBER: 231172981 BUSINESS ADDRESS: STREET 1: 221 ELM ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 212-659-3970 MAIL ADDRESS: STREET 1: 221 ELM ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 2seventy bio, Inc. CENTRAL INDEX KEY: 0001860782 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863658454 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 4 1 ownership.xml X0508 4 2023-08-10 0 0001860782 2seventy bio, Inc. TSVT 0001907884 Kynam Capital Management, LP 221 ELM ROAD PRINCETON NJ 08540 0 0 1 0 0 Common Stock, par value $0.0001 per share 2023-08-10 4 P 0 179000 5.94 A 5703825 I See Footnote Common Stock, par value $0.0001 per share 2023-08-10 4 P 0 50000 5.80 A 5753825 I See Footnote Common Stock, par value $0.0001 per share 2023-08-10 4 P 0 100000 5.85 A 5853825 I See Footnote Common Stock, par value $0.0001 per share 2023-08-10 4 P 0 100000 5.96 A 5953825 I See Footnote Common Stock, par value $0.0001 per share 2023-08-10 4 P 0 86414 5.96 A 5142111 D Common Stock, par value $0.0001 per share 2023-08-10 4 P 0 86414 5.96 A 5142111 I See Footnote The reported securities are owned directly by Kynam Global Healthcare Master Fund, LP (the "Master Fund"), a private investment fund managed by Kynam Capital Management, LP (the "Adviser"), and separately managed account clients of the Adviser and may be deemed to be indirectly beneficially owned by (i) the Adviser, (ii) Kynam Capital Management GP, LLC (the "Adviser GP"), the general partner of the Adviser and (iii) Yue Tang, the managing member of the Adviser GP. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The reported securities are directly owned by the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The reported securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by Kynam Fund GP, LLC, the general partner of the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. KYNAM CAPITAL MANAGEMENT, LP, By: KYNAM CAPITAL MANAGEMENT GP, LLC, By: /s/ Yue Tang, Yue Tang, Managing Member 2023-08-14